Fig. 6: Steroid treatment did not correlate with SARS-CoV-2 antibody titers in hospitalized participants. | Communications Medicine

Fig. 6: Steroid treatment did not correlate with SARS-CoV-2 antibody titers in hospitalized participants.

From: SARS-CoV-2 humoral immune responses in convalescent individuals over 12 months reveal severity-dependent antibody dynamics

Fig. 6: Steroid treatment did not correlate with SARS-CoV-2 antibody titers in hospitalized participants.

a Anti-N IgG levels and b anti-RBD IgG levels in hospitalized participants across 1, 3, 6, and 12 months post-SARS-CoV-2 infection, stratified by treatment with (+) and without (−) steroid. Anti-N titers sample sizes (n): 1 month −steroid (n = 7), +steroid (n = 35); 3 months −steroid (n = 8), +steroid (n = 28); 6 months −steroid (n = 8), +steroid (n = 31); 12 months −steroid (n = 7), +steroid (n = 23). Anti-RBD titers sample sizes (n): 1 month −steroid (n = 7), +steroid (n = 32); 3 months −steroid (n = 7), +steroid (n = 18); 6 months −steroid (n = 4), +steroid (n = 10); 12 months −steroid (n = 0), +steroid (n = 5). Pairwise comparisons of titers in participants treated with and without steroids were performed using the Wilcoxon test (p > 0.05 for all comparisons).

Back to article page